Armistice Capital »

Dare Bioscience shares owned by Armistice Capital

Quarter-by-quarter ownership of Dare Bioscience (DARE) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Dare Bioscience

Tip: Access up to 7 years of quarterly data

All positions including Dare Bioscience held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dare Bioscience by Armistice Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $3.0M 6.5M 0.46

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Argenx Se Sponsored Adr (ARGX)
Supernus Pharmaceuticals (SUPN)
Ptc Therapeutics I (PTCT)
Neurocrine Biosciences (NBIX)
Agios Pharmaceuticals (AGIO)
Biogen Idec (BIIB)
Colgate-Palmolive Company (CL)
Travere Therapeutics (TVTX)
Nevro (NVRO)
Amazon (AMZN)
Dentsply Sirona (XRAY)
Regeneron Pharmaceuticals (REGN)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Armistice Capital

Top funds holding Dare Bioscience

Vanguard Group
T. Rowe Price Associates
Founders Financial Securities
Commonwealth Equity Services
Wealth Enhancement Advisory Services
Charles Schwab Investment Management
Objectivity Squared
Asset Management Investors
Bank of New York Mellon
Raymond James Financial Services Advisors
Advisory Services Network
Virtu Financial
Jpmorgan Chase & Co
First Affirmative Financial Network
IFS Advisors

View all funds holding Dare Bioscience